secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK:        0001062822
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001062822-26-000065
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 3.02, 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexicon doubles authorized shares to 900M, adopts expanded 2026 equity plans
----------------------------------------------------------------------------

- Authorized common stock increased from 450M to 900M via Seventh Amended and Restated Certificate of Incorporation.
- Stockholders approved 2026 Equity Incentive Plan, raising share reserve from 75M to 90M shares.
- 2026 Non-Employee Directors' Equity Incentive Plan approved, increasing pool from 4M to 6M shares.
- All 408,434.7 shares of Series B Convertible Preferred converted into 20,421,735 common shares.
- All director nominees elected and other proposals passed with strong majority votes (e.g., auditor ratification 99.3% for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1062822/000106282226000065/0001062822-26-000065-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1062822/000106282226000065/lxrx-20260430.htm
  HTML page:      https://secwatch.observer/filing/0001062822-26-000065

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer